CDVZX | RMFCX | CDVZX / RMFCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 14 years | 23 years | - |
Gain YTD | 4.385 | 3.187 | 138% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 250 | 800% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.53B | 105B | 2% |
Annual Yield % from dividends | 1.73 | 1.69 | 102% |
Returns for 1 year | 11.77 | 12.29 | 96% |
Returns for 3 years | 7.59 | 16.30 | 47% |
Returns for 5 years | 27.02 | 40.36 | 67% |
Returns for 10 years | 35.70 | 65.40 | 55% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HCACX | 25.62 | 0.11 | +0.43% |
Hartford Capital Appreciation C | |||
UIPMX | 21.40 | 0.03 | +0.14% |
Victory Precious Metals & Minerals Instl | |||
WLCVX | 21.88 | N/A | N/A |
Wilshire Large Company Value Instl | |||
FIJYX | 29.17 | -0.15 | -0.51% |
Fidelity Advisor Biotechnology Z | |||
FEREX | 10.71 | -0.10 | -0.93% |
First Eagle Global Real Assets I |